Lifevantage Corp (LFVN): EPS (Diluted)
$0.40
Year ended 2026-06-30
+26.0%
3-year compound annual growth
-15.0%
5-year compound annual growth
-0.5%
10-year compound annual growth
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $0.40 | -46.7% | 2026-08-27, From 2025-07-01 |
| 2025-06-30 | $0.75 | +226.1% | 2026-08-27, From 2024-07-01 |
| 2024-06-30 | $0.23 | +15.0% | 2025-09-04, From 2023-07-01 |
| 2023-06-30 | $0.20 | -16.7% | 2024-08-28, From 2022-07-01 |
| 2022-06-30 | $0.24 | -73.3% | 2023-08-28, From 2021-07-01 |
| 2021-06-30 | $0.90 | +13.9% | 2022-08-23, From 2020-07-01 |
| 2020-06-30 | $0.79 | +58.0% | 2022-08-23, From 2019-07-01 |
| 2019-06-30 | $0.50 | +22.0% | 2021-08-19, From 2018-07-01 |
| 2018-06-30 | $0.41 | +272.7% | 2020-08-18, From 2017-07-01 |
| 2017-06-30 | $0.11 | -73.8% | 2019-08-14, From 2016-07-01 |
| 2016-06-30 | $0.42 | -16.0% | 2018-08-15, From 2015-07-01 |
| 2015-06-30 | $0.50 | -29.6% | 2017-09-07, From 2014-07-01 |
| 2014-06-30 | $0.71 | n/c | 2016-12-12, From 2013-07-01 |
| 2013-06-30 | $0.06 | -45.5% | 2015-09-01, From 2012-07-01 |
| 2012-06-30 | $0.11 | n/m | 2014-09-10, From 2011-07-01 |
| 2011-06-30 | -$0.69 | n/a | 2013-09-12, From 2010-07-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Lifevantage Corp (LFVN) | 2026-06-30 | $0.40 | -46.7% |
| Stoke Therapeutics, Inc. (STOK) | 2025-12-31 | -$0.12 | n/m |
| Maravai Lifesciences Holdings, Inc. (MRVI) | 2025-12-31 | -$0.90 | n/m |
| Cryoport, Inc. (CYRX) | 2025-12-31 | $1.40 | n/m |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | -$3.11 | n/m |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | -$3.03 | n/m |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | -$3.29 | n/m |
| Liquidia Corp (LQDA) | 2025-12-31 | -$0.80 | n/m |
| Amarin Corp PLC (AMRN) | 2025-12-31 | -$0.09 | n/m |
Compare LFVN, STOK, MRVI, CYRX side by side · Screen every company in Pharmaceutical Preparations ↗